UK life sciences innovation touted by Prime Minister at J P Morgan conf

The UK life science sector is playing a leading role at this year’s JP Morgan healthcare conference, being held virtually, the traditional kick off annual event for the global life science investment community.

Today, Prime Minister Boris Johnson opened the UK keynote session “partnering for Precision Medicine and Population Health” encouraging global investors to “choose the UK as the place to discover, innovate and find the solutions for the future.”

Citing the UK as the best place in the world for partnership working, he said: “From the outset of the pandemic, the British government worked hand-in-glove with academia and global life science companies to create the partnerships that allowed about half of all the genomic sequencing of new variants to take place in the UK, and of course produced the world’s most popular vaccine.”

As the only global political leader invited to speak to the conference, he showcased the  UK Life Sciences Vision, the government and UK life science sector's joint plan to create a thriving UK sector, and tackle the major causes of death and disease to global investors saying: “Now we want to apply this formula to the biggest healthcare problems of our age, including cancer, dementia and obesity.  Our aim is to work side-by-side with each and every one of you, mobilizing the UK’s national expertise in every field, from clinical research to genomics to health data, to test and trial innovations on a scale big enough to deliver solutions for the world.”